| Issue Date | Title | Author(s) |
| 2022-01-01 | Biogenic metal sulfide nanoparticles synthesis and applications for biomedical and environmental technology | Ragu Nandhakumar, S; Rajeshkumar, S; Anand, RS; Malyla, V; Dua, K; Ezhilarasan, D; Lakshmi, T |
| 2022-01-01 | A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers | Charbe, NB; Castillo, F; Tambuwala, MM; Prasher, P; Chellappan, DK; Carreño, A; Satija, S; Singh, SK; Gulati, M; Dua, K; González-Aramundiz, JV; Zacconi, FC |
| 2022-01-01 | Pediatric Medication Noninitiation in Spain. | Carbonell-Duacastella, C; Rubio-Valera, M; Marqués-Ercilla, S; Peñarrubia-María, MT; Gil-Girbau, M; Garcia-Cardenas, V; Pasarín, MI; Parody-Rúa, E; Aznar-Lou, I |
| 2022-11-22 | Role of flavonoids in management of various biological targets in Alzheimer's Disease: evidence from preclinical to clinical studies. | Alharbi, KS; Javed Shaikh, MA; Imam, SS; Alshehri, S; Ghoneim, MM; Almalki, WH; Singh, SK; Kumar, D; Kumar, AP; Dua, K; Chellappan, DK; Paudel, KR; Gupta, G |
| 2022-01-01 | Advanced drug delivery systems targeting metabolic disorders: erythropoietic protoporphyria | Verma, N; Thapa, K; Kanojia, N; Dureja, H; Dua, K |
| 2022-01-01 | Advanced drug delivery system in the treatment of hyperglycemia and hypoglycemia | Arora, V; Kabra, A; Sharma, RB; Dureja, H; Dua, K |
| 2022-01-01 | Advanced drug delivery systems targeting to improve therapeutic outcomes in porphyria | Basetty, V; Deruiter, J; Pathak, S; Dua, K; Dhanasekaran, M |
| 2022-01-01 | Drug Delivery Systems for Metabolic Disorders | Dureja, H; Murthy, NN; Wich, PR; Dua, K |
| 2022-01-01 | Emerging drug delivery in the treatment of hyperpituitarism and hypopituitarism | Arora, V; Kabra, A; Puri, R; Vyas, G; Dua, K; Dureja, H |
| 2022-01-01 | Drug delivery systems in Krabbe disease—present and prospective approaches | Prabitha Priyadharshini, A; Umamaheswari, A; Vijayalakshmi, M; Chellappan, DK; Dua, K; Prabu, SL |
